Sertraline Against Depression and Heart Disease in Chronic Heart Failure - SADHART-CHF

Description:

Depression is a common comorbidity in patients with chronic heart failure (CHF). The SADHART-CHF trial sought to study if treatment with an antidepressant, sertraline (a selective serotonin reuptake inhibitor [SSRI]) would be associated with benefit in patients with CHF and depression.